Cannovum is pleased to announce a strategic supply partnership for Dronabinol with a European medical cannabis supplier. Products are expected to be sold starting from August as part of the Cannovum brand range.
Priv. Doz. Dr. med. habil. Philipp Sewerin is the new member of the supervisory board as well as the Medical Advisory Board. Dr. Sewerin is a specialist in internal medicine and rheumatology at the university clinic in Düsseldorf.
Cannovum took the first step and founded Cannovum Iberia LDA, a joint venture between Cannovum and Portuguese entrepreneurs from the cannabis industry.
© 2021 Cannovum AG. All rights reserved.
